A Near‐Infrared‐Controllable Artificial Metalloprotease Used for Degrading Amyloid‐β Monomers and Aggregates

作者: Mengmeng Ma , Ying Wang , Nan Gao , Xinping Liu , Yuhuan Sun

DOI: 10.1002/CHEM.201902828

关键词:

摘要: Proteolysis of amyloid-β (Aβ) is a promising approach against Alzheimer's disease. However, it not feasible to employ natural hydrolases directly because their cumbersome preparation and purification, poor stability, hazardous immunogenicity. Therefore, artificial enzymes have been developed as potential alternatives hydrolases. Since specific cleavage sites Aβ are usually embedded inside the β-sheet structures that restrict access by enzymes, this strongly hinders efficiency for practical applications. Herein, we construct NIR (near-IR) controllable metalloprotease (MoS2 -Co) using molybdenum disulfide nanosheet ) cobalt complex 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (Codota). Evidenced detailed experimental theoretical studies, NIR-enhanced MoS2 -Co can circumvent restriction simultaneously inhibition formation destroying preformed aggregates in living cell. Furthermore, our designed an easy graft Aβ-target agent prevents misdirected or undesirable hydrolysis reactions, has demonstrated cross blood brain barrier. This method be adapted other kinds amyloids.

参考文章(40)
Ram Prasad Bora, Arghya Barman, Xiaoxia Zhu, Mehmet Ozbil, Rajeev Prabhakar, Which one among aspartyl protease, metallopeptidase, and artificial metallopeptidase is the most efficient catalyst in peptide hydrolysis? Journal of Physical Chemistry B. ,vol. 114, pp. 10860- 10875 ,(2010) , 10.1021/JP104294X
Bong-Seop Lee, Takayuki Amano, Hong Qiang Wang, Joe L. Pantoja, Chi Woo Yoon, Christopher J. Hanson, Rina Amatya, Allen Yen, Keith L. Black, John S. Yu, Reactive Oxygen Species Responsive Nanoprodrug to Treat Intracranial Glioblastoma ACS Nano. ,vol. 7, pp. 3061- 3077 ,(2013) , 10.1021/NN400347J
Claudio Soto, Einar M. Sigurdsson, Laura Morelli, R. Asok Kumar, Eduardo M. Castaño, Blas Frangione, Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nature Medicine. ,vol. 4, pp. 822- 826 ,(1998) , 10.1038/NM0798-822
Tingting Zhang, Mehmet Ozbil, Arghya Barman, Thomas J. Paul, Ram Prasad Bora, Rajeev Prabhakar, Theoretical insights into the functioning of metallopeptidases and their synthetic analogues. Accounts of Chemical Research. ,vol. 48, pp. 192- 200 ,(2015) , 10.1021/AR500301Y
Cristina Rodríguez-Rodríguez, Maria Telpoukhovskaia, Chris Orvig, The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases Coordination Chemistry Reviews. ,vol. 256, pp. 2308- 2332 ,(2012) , 10.1016/J.CCR.2012.03.008
Aaron Ciechanover, Yong Tae Kwon, Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies Experimental and Molecular Medicine. ,vol. 47, pp. 1- 16 ,(2015) , 10.1038/EMM.2014.117
Todd E. Golde, Lon S. Schneider, Edward H. Koo, Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift Neuron. ,vol. 69, pp. 203- 213 ,(2011) , 10.1016/J.NEURON.2011.01.002
Teng Liu, Chao Wang, Xing Gu, Hua Gong, Liang Cheng, Xiaoze Shi, Liangzhu Feng, Baoquan Sun, Zhuang Liu, Drug Delivery with PEGylated MoS2 Nano‐sheets for Combined Photothermal and Chemotherapy of Cancer Advanced Materials. ,vol. 26, pp. 3433- 3440 ,(2014) , 10.1002/ADMA.201305256
Shige Wang, Kai Li, Yu Chen, Hangrong Chen, Ming Ma, Jingwei Feng, Qinghua Zhao, Jianlin Shi, None, Biocompatible PEGylated MoS2 nanosheets: controllable bottom-up synthesis and highly efficient photothermal regression of tumor. Biomaterials. ,vol. 39, pp. 206- 217 ,(2015) , 10.1016/J.BIOMATERIALS.2014.11.009
Yi-An Lin, Yu-Chuan Ou, Andrew G. Cheetham, Honggang Cui, Rational design of MMP degradable peptide-based supramolecular filaments. Biomacromolecules. ,vol. 15, pp. 1419- 1427 ,(2014) , 10.1021/BM500020J